This paper investigated the effects of ascorbic acid preservation, storage at 4˚C, storage at -80˚C, and freeze-thaw cycling on levels of estrogen metabolites (EM) in urine.
Stability of 15 estrogens and estrogen metabolites in urine samples under processing and storage conditions typically used in epidemiologic studies.
Fuhrman BJ, Xu X, Falk RT, Hankinson SE, Veenstra TD, Keefer LK, Ziegler RG
Purpose
Conclusion
Although effects of storage on individual EM were noted for each of the three patients, no significant effect of storage at 4˚C for up to 48 h, storage at -80˚C for up to 1 year, or up to 3 freeze-thaw cycles was consistent across the patients. Importantly, the addition of ascorbic acid did not increase the stability of analytes and in the case of 4˚C storage, resulted in more analytes being significantly changed in urine from a single patient.
Studies (2)
Purpose
This study investigated the effects of ascorbic acid preservation, timing during menstrual cycle and storage at 4˚C for 48 h on levels of estrogen metabolites in urine. First morning urine was collected from two women during the luteal phase of the menstrual cycle and one woman in follicular phase of the menstrual cycle. Immediately after collection, the specimen was split and 0.1% (W/V) ascorbic acid was added to half while the other half of the specimen remained untreated. To investigate the effects of short-term refrigerated storage, six treated and six untreated aliquots from each patient were immediately frozen at -80˚C and three treated and three untreated aliquots from each patient were stored at 4˚C for 1, 2, 4, 8, 24, 32, or 48 hours before freezing at -80˚C. Estrogens and estrogen metabolites were quantified by LC-MS/MS.
Summary of Findings
As expected, urinary levels of estradiol and estrone were higher in the woman in the follicular phase of the menstrual cycle than in the two women in the luteal phase. Importantly, levels of individual estrogen metabolites in each individual varied by more than 2-orders of magnitude with 4-methoxyestradiol found at the lowest concentrations in all three patients, but different estrogen metabolites were found to be the most common in each of the three patients.
Short-term storage at 4˚C without ascorbic acid did not significantly affect levels of any analyte in specimens from all three patients but 2-hydroxyestradiol increased by 1.1% after 24 h (P=0.05) in one patient and estradiol concentrations declined by 0.1% in the first 24 h (P=0.04) in another patient. Similarly, when ascorbic acid was added, short-term storage at 4˚C did not affect levels of any one analyte in specimens from all three patients, but significant increases after 24 h were found for 4-methoxyestrone (6.6%, P<0.001), estriol (1.0%, P=0.01), and 16-epiestriol (0.5%, P=0.03) and significant declines after 24 h were found for 4-methoxyestradiol (5.7%, P trend= 0.03) for one patient and the other two patients had significant increases after 24 h in levels of 2-hydroxyestrone-3-methyl ether (1.1%, P=0.01 and 0.3% P=03). Specimens preserved with acetic acid showed smaller changes in 2-hydroxyestrone and larger changes in 2-hydroxyestrone-3-methyl ether, 4-methoxyestrone, and estriol during 4˚C storage in a single woman each.
Biospecimens
FluidUrinePreservation Types
FrozenDiagnoses
Not specifiedPlatforms
SteroidLC-MS or LC-MS/MSPre-analytical Factors
Classification Pre-Analytical Factor Value(s) Preaquisition Diagnosis/ patient condition Follicular phase of menstrual cycleLuteal phase of menstrual cycleBiospecimen Preservation Type of fixation/preservation Ascorbic acidRefrigerationStorage Storage duration 1 h2 h24 h32 h4 h48 h8 h
Purpose
This study investigated the effects of ascorbic acid preservation, storage at -80˚C for up to 1 year and freeze-thaw cycling on levels of estrogen metabolites in urine. First morning urine was collected from two women during the luteal phase of the menstrual cycle and one woman in follicular phase of the menstrual cycle. Immediately after collection the specimen was split and 0.1% (W/V) ascorbic acid was added to half while the other half of the specimen remained untreated. The effects of long-term storage effects were examined by storing three treated and three untreated urine aliquots from each of two patients for 1 day, 7 days, 14 days, 1 month, 2 months, 3months, 4 months, 5 months, 6 months, and 1 year at -80˚C. The effects of freeze-thaw cycling were investigated using aliquots of urine with and without ascorbic acid from two patients and aliquots without ascorbic acid from one patient by thawing in an ice bath for 4 h and refreezing at -80˚C for at least 18 h before thawing again. Estrogens and estrogen metabolites were quantified by LC-MS/MS.
Summary of Findings
Storage at -80˚C with or without ascorbic acid did not result in significant changes in the levels of any one estrogen metabolite in specimens from both patients. However, 4-methoxyestrone increased by 5.2% (P = 0.01) over the year of storage without ascorbic acid in one patient and estriol increased by 0.3% (P=0.05) in the other and 2-hydroxyestradiol decreased by 1.0% (P =0.05) and 2-hydroxyestrone-3-methyl ether decreased by 2.3% (P=0.01) over the year of storage with ascorbic acid in urine from one patient while 4-methoxyestradiol declined by 1.2% (P=0.01) in urine from the other patient. The percent change in levels of 2-hydroxyestrone, and 4-methoxyestradiol was affected by the addition of ascorbic acid in one patient.
Freeze-thaw cycles did not significantly alter levels of any of the estrogen metabolites in all three patients, regardless of the addition of ascorbic acid. However, levels of 17-epiestriol in urine declined 2.5% per cycle over two cycles in one patient when no ascorbic acid was added (P=0.02) and levels of 4-hydroxyestrone declined 2.2% per cycle over two cycles in another patient when ascorbic acid was added (P=0.01). In neither case was the change significantly affected by the addition of ascorbic acid.
Biospecimens
FluidUrinePreservation Types
FrozenDiagnoses
Not specifiedPlatforms
SteroidLC-MS or LC-MS/MSPre-analytical Factors
Classification Pre-Analytical Factor Value(s) Biospecimen Preservation Type of fixation/preservation Ascorbic acidFrozenStorage Freeze/thaw cycling 1 cycle2 cycles3 cyclesStorage Storage duration 1 day1 month1 year14 days2 months3 months4 months5 months6 months7 days